These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 20607500)

  • 1. TBK1-targeted suppression of TRIF-dependent signaling pathway of toll-like receptor 3 by auranofin.
    Park SJ; Lee AN; Youn HS
    Arch Pharm Res; 2010 Jun; 33(6):939-45. PubMed ID: 20607500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of homodimerization of Toll-like receptor 4 by curcumin.
    Youn HS; Saitoh SI; Miyake K; Hwang DH
    Biochem Pharmacol; 2006 Jun; 72(1):62-9. PubMed ID: 16678799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea.
    Youn HS; Lee JY; Saitoh SI; Miyake K; Kang KW; Choi YJ; Hwang DH
    Biochem Pharmacol; 2006 Sep; 72(7):850-9. PubMed ID: 16890209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin.
    Lee JK; Kim SY; Kim YS; Lee WH; Hwang DH; Lee JY
    Biochem Pharmacol; 2009 Apr; 77(8):1391-400. PubMed ID: 19426678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoliquiritigenin suppresses the Toll-interleukin-1 receptor domain-containing adapter inducing interferon-beta (TRIF)-dependent signaling pathway of Toll-like receptors by targeting TBK1.
    Park SJ; Youn HS
    J Agric Food Chem; 2010 Apr; 58(8):4701-5. PubMed ID: 20356041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selenium suppresses the activation of transcription factor NF-kappa B and IRF3 induced by TLR3 or TLR4 agonists.
    Youn HS; Lim HJ; Choi YJ; Lee JY; Lee MY; Ryu JH
    Int Immunopharmacol; 2008 Mar; 8(3):495-501. PubMed ID: 18279804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guggulsterone suppresses the activation of transcription factor IRF3 induced by TLR3 or TLR4 agonists.
    Youn HS; Ahn SI; Lee BY
    Int Immunopharmacol; 2009 Jan; 9(1):108-12. PubMed ID: 19000789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
    Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S
    Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Akt contributes to activation of the TRIF-dependent signaling pathways of TLRs by interacting with TANK-binding kinase 1.
    Joung SM; Park ZY; Rani S; Takeuchi O; Akira S; Lee JY
    J Immunol; 2011 Jan; 186(1):499-507. PubMed ID: 21106850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR3-mediated IFN-β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like.
    Siednienko J; Halle A; Nagpal K; Golenbock DT; Miggin SM
    Eur J Immunol; 2010 Nov; 40(11):3150-60. PubMed ID: 20957750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR3 signaling in a hepatoma cell line is skewed towards apoptosis.
    Khvalevsky E; Rivkin L; Rachmilewitz J; Galun E; Giladi H
    J Cell Biochem; 2007 Apr; 100(5):1301-12. PubMed ID: 17243100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
    Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN
    Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Andrographolide suppresses TRIF-dependent signaling of toll-like receptors by targeting TBK1.
    Kim AY; Shim HJ; Shin HM; Lee YJ; Nam H; Kim SY; Youn HS
    Int Immunopharmacol; 2018 Apr; 57():172-180. PubMed ID: 29518743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of TRIF-dependent signaling pathway of toll-like receptors by allyl isothiocyanate in RAW 264.7 macrophages.
    Kim SJ; Park HJ; Shin HJ; Shon DH; Kim DH; Youn HS
    Int Immunopharmacol; 2012 Aug; 13(4):403-7. PubMed ID: 22668719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of TRIF-dependent signaling pathway of toll-like receptors by (E)-1-(2-(2-nitrovinyl)phenyl)pyrrolidine.
    Gu GJ; Eom SH; Suh CW; Koh KO; Kim DY; Youn HS
    Eur J Pharmacol; 2013 Dec; 721(1-3):109-15. PubMed ID: 24080550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response.
    Oganesyan G; Saha SK; Guo B; He JQ; Shahangian A; Zarnegar B; Perry A; Cheng G
    Nature; 2006 Jan; 439(7073):208-11. PubMed ID: 16306936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TBK1-targeted suppression of TRIF-dependent signaling pathway of Toll-like receptors by helenalin.
    Shin HJ; Youn HS
    Life Sci; 2013 Nov; 93(22):847-54. PubMed ID: 24044884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF receptor-associated factor-1 (TRAF1) negatively regulates Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling.
    Su X; Li S; Meng M; Qian W; Xie W; Chen D; Zhai Z; Shu HB
    Eur J Immunol; 2006 Jan; 36(1):199-206. PubMed ID: 16323247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of the TRIF-dependent signaling pathway of Toll-like receptor by CDr10b in RAW264.7 macrophages.
    Gu GJ; Ahn SI; Kim JS; Hong CY; Lee SC; Chang YT; Choi TH; Kim BS; Youn HS
    Int Immunopharmacol; 2015 Sep; 28(1):29-33. PubMed ID: 26004315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex.
    Youn HS; Lee JY; Fitzgerald KA; Young HA; Akira S; Hwang DH
    J Immunol; 2005 Sep; 175(5):3339-46. PubMed ID: 16116226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.